A Glimpse Into The Expert Outlook On Sarepta Therapeutics Through 15 Analysts
A Glimpse Into The Expert Outlook On Sarepta Therapeutics Through 15 Analysts
通過15位分析師對Sarepta Therapeutics的專家展望
The perception...15 analysts have expressed a variety of opinions on Sarepta Therapeutics (NASDAQ:SRPT) over the past quarter, offering a diverse set of opinions from bullish to bearish.
過去一個季度，15位分析師對Sarepta Therapeutics (納斯達克:SRPT)表達了各種不同的觀點，從看好到看淡都有。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們近期評級的彙總視圖，展示了過去30天的情緒變化，並將其與前幾個月進行了比較。
Analysts have recently evaluated Sarepta Therapeutics and provided 12-month price targets. The average target is $158.87, accompanied by a high estimate of $205.00 and a low estimate of $75.00. This current average has decreased by 5.25% from the previous average price target of $167.67.
分析師最近對Sarepta Therapeutics進行了評估，並提供了12個月的價格目標。平均目標爲158.87美元，最高估計爲205.00美元，最低估計爲75.00美元。當前的平均值比之前的平均價格目標167.67美元下降了5.25%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀：深入分析
The perception...
金融...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。